A series of pediatric patients with inflammatory bowel disease switching from intravenous to subcutaneous infliximab maintenance therapy. - Duquerois AS; Martinez-Vinson C; Loppinet T; Restier L; Poinsot P; Portefaix A; Heissat S; Peretti N; Caron N; Duclaux-Loras R (Clinics and research in hepatology and gastroenterology, 2025)